Connect with us

Business

Does the US Have an Efficient Cannabis Market Already? – First Day Cannabis Sales in Connecticut Barely Break $300,000

Published

on

Recreational cannabis sales barely break $350k in Connecticut on day #1

On a Tuesday a few weeks ago, Connecticut officially opened its doors to the legal adult-use cannabis market. The state’s cannabis retailers generated more than $359,130 on the first day of regulated sales. This marks a significant turning point for the state, as it joins the growing number of states across the country that have legalized marijuana for recreational use.

The effort to legalize adult-use cannabis in Connecticut was led by Democratic politicians, including Governor Ned Lamont, who argued that regulating the cannabis industry would protect consumers and help communities affected by the War on Drugs. In June 2021, Governor Lamont signed legislation ending the prohibition of recreational marijuana, legalizing possession for adults 21 and older, and developing a framework for regulated adult-use sales. The measure also included restorative justice and social equity measures, including expunging nearly 43,000 marijuana-related convictions on New Year’s Day.

Market rollout

The state’s cannabis market is starting small, with only seven existing medical marijuana dispensaries being granted licenses to sell recreational marijuana as “hybrid retailers.” These dispensaries, located in Branford, Meriden, Montville, New Haven, Newington, Stamford, and Willimantic, opened their doors to recreational customers on Tuesday morning. By 5 p.m., the seven shops had sold $359,130 worth of cannabis products to recreational customers, according to the Connecticut Department of Consumer Protection.

Customers were confronted with higher costs than those in Massachusetts, a neighboring state. A comparison of prices online revealed that a packet of 100-milligram edibles at a dispensary in Stamford cost $40 before tax, whereas a comparable product with an identical THC content of 100 milligrams cost $25 at the company’s Rowley, Massachusetts location. According to reports, equivalent goods cost $25 in New Jersey and $35 in Rhode Island, respectively.

Cannabis marketplaces typically launch with higher-than-average pricing, but prices frequently decline and settle as the market matures. President of the Connecticut Cannabis Chamber of Commerce, Adam Wood, predicts that when supply and demand shift, “prices will fluctuate.” Only four licensed growers exist in the state at the moment. According to Wood, the state may grant permits to up to 30 to more than 40 cultivators.

Democratic State Senator Matt Lesser attended a ribbon-cutting ceremony to mark the launch of recreational sales at the Fine Fettle cannabis dispensary in Newington. He noted that starting recreational sales at a few shops, and implementing reservation systems, helped control crowds and prevent traffic backups on local roads. He also highlighted the importance of starting small, saying, “Starting small is the smart way to do it and allows us to really learn from other states and work out any kinks we may have in the new system.”

Despite his support for cannabis policy reform, Lesser expressed concerns about legalizing recreational marijuana, specifically the potential for people to drive under the influence. He also emphasized the importance of generating revenue for substance abuse prevention and treatment programs and bringing the industry out of the shadows and into a regulated framework.

In a statement commemorating the event, Governor Lamont stated, “Today marks the beginning of the end for the injustices caused by the war on drugs, seeing as there is now a legal alternative to the risky, uncontrolled, and the illegal cannabis industry.” “We’ve carefully constructed a safely regulated market that emphasizes public health, public safety, social justice, and equity,” he continued, “along with our colleagues in the legislature and our team of specialists at the Department of Consumer Protection. I’m eager to keep working to make sure this sector continues to grow inclusively and safely.

Expected Challenges

One of the challenges facing the cannabis industry in Connecticut is the higher prices compared to neighboring states. This is not uncommon for new adult-use cannabis markets, as prices usually start high and come down as the market matures. However, it may be a barrier for some consumers. It may encourage them to continue patronizing illegal sources, potentially harming the new market’s success in the short term.

Additionally, the limited number of cultivators and dispensaries currently operating in the state may contribute to the higher prices. As the number of cultivators increases and more dispensaries open, it will likely lead to increased competition and lower consumer prices. Adam Wood explained that more cultivators would begin to enter the market in no time to crash the current prices.

Another challenge for the cannabis industry in Connecticut is the limited access to capital for small businesses and those from marginalized communities. This is a common issue in the cannabis industry, and the state needs to address it to create a better, inclusive and equitable market. One solution could be to establish a social equity program, similar to those in other states, that provides financial assistance and business support to these groups.

For instance, California’s social equity program prioritizes and helps people from neighborhoods that the War has disproportionately impacted on Drugs get cannabis licenses. The initiative offers these people financial and technical support to help them get their cannabis enterprises off the ground and navigate the licensing procedure.

In a few months, two brand-new medicinal marijuana dispensaries in Torrington and Danbury are anticipated to start accepting recreational users. This is just the beginning of what to expect in the coming months as Connecticut continues to navigate the challenges of the cannabis sector and tries to create a more inclusive and equitable market.

It is important to note that marijuana is still illegal under federal law, and the U.S. government has not said how it will deal with states that legalize it. However, the Biden Administration has indicated that it will not prioritize the enforcement of federal marijuana laws in states that have legalized marijuana.

Final Note

The launch of the legal adult-use cannabis market in Connecticut marks a significant step forward in the ongoing effort to end the prohibition of marijuana and create a regulated, safe and inclusive market. With the support of politicians and the community, Connecticut can serve as a model for other states looking to legalize marijuana and work toward social justice and equity.

Source: https://cannabis.net/blog/news/does-the-us-have-an-efficient-cannabis-market-already-first-day-cannabis-sales-in-connecticut-b

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News